Cargando…

Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis

BACKGROUND: Human immunodeficiency virus (HIV) is the strongest known risk factor for tuberculosis (TB) through its impairment of T-cell immunity. Tuberculosis preventive treatment (TPT) is recommended for people living with HIV (PLHIV) by the World Health Organization, as it significantly reduces t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uppal, Aashna, Rahman, Samiha, Campbell, Jonathon R., Oxlade, Olivia, Menzies, Dick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439468/ https://www.ncbi.nlm.nih.gov/pubmed/34520463 http://dx.doi.org/10.1371/journal.pmed.1003712

Ejemplares similares

Tuberculosis preventive treatment in people living with HIV—Is the glass half empty or half full?
por: Oxlade, Olivia, et al.
Publicado: (2021)

Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis
por: Yanes-Lane, Mercedes, et al.
Publicado: (2021)

The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis
por: Bastos, Mayara Lisboa, et al.
Publicado: (2021)

The impact of improved detection and treatment of isoniazid resistant tuberculosis on prevalence of multi-drug resistant tuberculosis: A modelling study
por: Romanowski, Kamila, et al.
Publicado: (2019)

The potential impact and cost-effectiveness of tobacco reduction strategies for tuberculosis prevention in Canadian Inuit communities
por: N’Diaye, Dieynaba S., et al.
Publicado: (2019)

Social and behavioral risk reduction strategies for tuberculosis prevention in Canadian Inuit communities: a cost-effectiveness analysis
por: Uppal, Aashna, et al.
Publicado: (2021)

Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis
por: Bastos, Mayara Lisboa, et al.
Publicado: (2022)

Systematic on-site testing for SARS-CoV-2 infection among asymptomatic essential workers in Montréal, Canada: a prospective observational and cost-assessment study
por: Campbell, Jonathon R., et al.
Publicado: (2022)

Modeling the impact of tuberculosis interventions on epidemiologic outcomes and health system costs
por: Oxlade, Olivia, et al.
Publicado: (2015)

How Methodologic Differences Affect Results of Economic Analyses: A Systematic Review of Interferon Gamma Release Assays for the Diagnosis of LTBI
por: Oxlade, Olivia, et al.
Publicado: (2013)

Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study
por: Tseng, Chia-Lin, et al.
Publicado: (2011)

Impact of DOTS expansion on tuberculosis related outcomes and costs in Haiti
por: Jacquet, Vary, et al.
Publicado: (2006)

What’s Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2019)

Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016
por: Campbell, Jonathon R., et al.
Publicado: (2022)

Patients' Costs and Cost-Effectiveness of Tuberculosis Treatment in DOTS and Non-DOTS Facilities in Rio de Janeiro, Brazil
por: Steffen, Ricardo, et al.
Publicado: (2010)

Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis
por: Campbell, Jonathon R, et al.
Publicado: (2020)

Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis
por: Vesga, Juan F., et al.
Publicado: (2022)

Acceptability, feasibility, and impact of a pilot tuberculosis literacy and treatment counselling intervention: a mixed methods study
por: Law, Stephanie, et al.
Publicado: (2021)

Effects of programmatic interventions to improve the management of latent tuberculosis: a follow up study up to five months after implementation
por: Yanes-Lane, Mercedes, et al.
Publicado: (2021)

Economic Evaluation of Multiple-Pharmacogenes Testing for the Prevention of Adverse Drug Reactions in People Living with HIV
por: Turongkaravee, Saowalak, et al.
Publicado: (2022)

New opportunities in tuberculosis prevention: implications for people living with HIV
por: González Fernández, Lucia, et al.
Publicado: (2020)

Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2022)

Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis
por: Roscoe, Clay, et al.
Publicado: (2020)

Solutions to improve the latent tuberculosis Cascade of Care in Ghana: a longitudinal impact assessment
por: Barss, Leila, et al.
Publicado: (2020)

Triage of Persons With Tuberculosis Symptoms Using Artificial Intelligence–Based Chest Radiograph Interpretation: A Cost-Effectiveness Analysis
por: Nsengiyumva, Ntwali Placide, et al.
Publicado: (2021)

Tuberculosis and Poverty: Why Are the Poor at Greater Risk in India?
por: Oxlade, Olivia, et al.
Publicado: (2012)

Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis
por: Samuels, Joel Philip, et al.
Publicado: (2018)

Framework for the evaluation of new tests for tuberculosis infection
por: Hamada, Yohhei, et al.
Publicado: (2021)

Acceptability of Community-Based Tuberculosis Preventive Treatment for People Living with HIV in Zimbabwe
por: Msukwa, Martin K., et al.
Publicado: (2022)

Isoniazid prophylaxis: highly effective but underutilised to prevent tuberculosis in people living with HIV
por: Vojnov, Lara, et al.
Publicado: (2022)

Health economic analyses of latent tuberculosis infection screening and preventive treatment among people living with HIV in lower tuberculosis incidence settings: a systematic review
por: Baggaley, Rebecca F., et al.
Publicado: (2023)

Tuberculosis control in people living with HIV/AIDS
por: Magnabosco, Gabriela Tavares, et al.
Publicado: (2016)

The mTST – An mHealth approach for training and quality assurance of tuberculin skin test administration and reading
por: Moayedi-Nia, Saeedeh, et al.
Publicado: (2019)

A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis
por: Fox, Gregory J., et al.
Publicado: (2013)

The Impact of ART on the Economic Outcomes of People Living with HIV/AIDS
por: Nannungi, Annet, et al.
Publicado: (2013)

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2020)

Isoniazid Preventive Therapy for Prevention of Tuberculosis among People Living with HIV in Ethiopia: A Systematic Review of Implementation and Impacts
por: Assefa, Dawit Getachew, et al.
Publicado: (2022)

Beneficial Effect of Isoniazid Preventive Therapy and Antiretroviral Therapy on the Incidence of Tuberculosis in People Living with HIV in Ethiopia
por: Yirdaw, Kesetebirhan Delele, et al.
Publicado: (2014)

Isoniazid preventive therapy: Uptake, incidence of tuberculosis and survival among people living with HIV in Bulawayo, Zimbabwe
por: Nyathi, Saziso, et al.
Publicado: (2019)

Isoniazid Preventive Therapy for Tuberculosis in People Living with HIV: A Cross Sectional Study in Butebo, Uganda
por: Oonyu, Lawrence, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hmujeh62agv0n9ietal1o2aa48